$CHTR
CHARTER COMMUNICATIONS, INC. /MO/

2024 Q1 Form 10-Q Financial Statement

#000109166724000085 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $13.68B $13.71B
YoY Change 0.19% 0.27%
Cost Of Revenue $7.476B $7.390B
YoY Change -1.18% -0.89%
Gross Profit $6.203B $6.321B
YoY Change 1.89% 1.66%
Gross Profit Margin 45.35% 46.1%
Selling, General & Admin $920.0M $900.0M
YoY Change -2.75% 6.38%
% of Gross Profit 14.83% 14.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.190B $2.188B
YoY Change -0.73% -0.18%
% of Gross Profit 35.31% 34.61%
Operating Expenses $3.110B $3.088B
YoY Change -63.46% 1.65%
Operating Profit $3.093B $3.233B
YoY Change 5.71% 1.67%
Interest Expense -$1.406B -$1.408B
YoY Change 2.55% 13.18%
% of Operating Profit -45.46% -43.55%
Other Income/Expense, Net $1.000M -$221.0M
YoY Change -100.96% -1800.0%
Pretax Income $1.726B $1.635B
YoY Change 10.85% -9.37%
Income Tax $446.0M $406.0M
% Of Pretax Income 25.84% 24.83%
Net Earnings $1.106B $1.058B
YoY Change 8.33% -11.54%
Net Earnings / Revenue 8.09% 7.72%
Basic Earnings Per Share $7.66
Diluted Earnings Per Share $7.54 $7.04
COMMON SHARES
Basic Shares Outstanding 144.5M shares
Diluted Shares Outstanding 146.6M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $661.0M $709.0M
YoY Change 23.78% 9.92%
Cash & Equivalents $661.0M $709.0M
Short-Term Investments
Other Short-Term Assets $731.0M $458.0M
YoY Change 7.18% 1.55%
Inventory
Prepaid Expenses
Receivables $3.004B $2.965B
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.396B $4.132B
YoY Change 8.09% 2.86%
LONG-TERM ASSETS
Property, Plant & Equipment $40.35B $39.52B
YoY Change 10.24% 9.66%
Goodwill $29.67B $29.67B
YoY Change 0.36% 0.36%
Intangibles
YoY Change
Long-Term Investments $684.0M
YoY Change -30.98%
Other Assets $4.726B $4.732B
YoY Change -1.4% -0.78%
Total Long-Term Assets $143.6B $143.1B
YoY Change 2.02% 1.82%
TOTAL ASSETS
Total Short-Term Assets $4.396B $4.132B
Total Long-Term Assets $143.6B $143.1B
Total Assets $148.0B $147.2B
YoY Change 2.19% 1.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $850.0M $931.0M
YoY Change 13.94% -2.21%
Accrued Expenses $9.556B $9.774B
YoY Change 6.49% 7.5%
Deferred Revenue $509.0M
YoY Change -0.39%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.000B
YoY Change -100.0% 32.45%
Total Short-Term Liabilities $10.93B $13.21B
YoY Change -10.75% 9.52%
LONG-TERM LIABILITIES
Long-Term Debt $97.97B $95.78B
YoY Change 2.08% -0.33%
Other Long-Term Liabilities $4.581B $4.530B
YoY Change -3.01% -4.79%
Total Long-Term Liabilities $102.5B $100.3B
YoY Change 1.84% -0.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.93B $13.21B
Total Long-Term Liabilities $102.5B $100.3B
Total Liabilities $136.2B $113.5B
YoY Change 20.57% 0.54%
SHAREHOLDERS EQUITY
Retained Earnings -$11.15B -$12.26B
YoY Change -19.17% -17.28%
Common Stock $23.54B $23.35B
YoY Change -2.46% -2.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $516.0M $0.00
YoY Change -43.91%
Treasury Stock Shares
Shareholders Equity $11.87B $11.09B
YoY Change
Total Liabilities & Shareholders Equity $148.0B $147.2B
YoY Change 2.19% 1.85%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $1.106B $1.058B
YoY Change 8.33% -11.54%
Depreciation, Depletion And Amortization $2.190B $2.188B
YoY Change -0.73% -0.18%
Cash From Operating Activities $3.212B $3.855B
YoY Change -3.34% 1.8%
INVESTING ACTIVITIES
Capital Expenditures $2.791B $2.856B
YoY Change 13.27% -197.81%
Acquisitions
YoY Change
Other Investing Activities -$116.0M $212.0M
YoY Change -245.0% 39.47%
Cash From Investing Activities -$2.907B -$2.644B
YoY Change 6.13% -4.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$514.0M
YoY Change -156.36%
Debt Paid & Issued, Net $5.716B
YoY Change -15.19%
Cash From Financing Activities -353.0M -1.073B
YoY Change -49.21% 25.64%
NET CHANGE
Cash From Operating Activities 3.212B 3.855B
Cash From Investing Activities -2.907B -2.644B
Cash From Financing Activities -353.0M -1.073B
Net Change In Cash -48.00M 138.0M
YoY Change -56.76% -16.36%
FREE CASH FLOW
Cash From Operating Activities $3.212B $3.855B
Capital Expenditures $2.791B $2.856B
Free Cash Flow $421.0M $999.0M
YoY Change -50.99% -85.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15606000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14718000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
148044000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147193000000 usd
CY2024Q1 us-gaap Revenues
Revenues
13679000000 usd
CY2023Q1 us-gaap Revenues
Revenues
13653000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18966000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18954000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4581000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4530000000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23544000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23346000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11154000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12260000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1557554 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
516000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11874000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
11086000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
3732000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
3632000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
8396000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8511000000 usd
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2190000000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2206000000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
38000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10000000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
10548000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
10727000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3131000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2926000000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1316000000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1265000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-89000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104000000 usd
CY2024Q1 chtr Total Nonoperating Income Expense Including Interest Expense Net
TotalNonoperatingIncomeExpenseIncludingInterestExpenseNet
-1405000000 usd
CY2023Q1 chtr Total Nonoperating Income Expense Including Interest Expense Net
TotalNonoperatingIncomeExpenseIncludingInterestExpenseNet
-1369000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1726000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1557000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
374000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1280000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
174000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
162000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1106000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1021000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.66
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.74
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.55
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.65
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144510317 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151438371 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146643199 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153538359 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14718000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1280000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
516000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
86000000 usd
CY2024Q1 chtr Noncontrolling Interest Increase Decrease From Changes In Subsidiary Ownership
NoncontrollingInterestIncreaseDecreaseFromChangesInSubsidiaryOwnership
-3000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15606000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12549000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
208000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
920000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
108000000 usd
CY2023Q1 chtr Noncontrolling Interest Increase Decrease From Changes In Subsidiary Ownership
NoncontrollingInterestIncreaseDecreaseFromChangesInSubsidiaryOwnership
-9000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1280000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2190000000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2206000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
208000000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8000000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-3000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23000000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-104000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
366000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
336000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-111000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-86000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3212000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3323000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2791000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2464000000 usd
CY2024Q1 chtr Changes In Accrued Expenses Related To Capital Expenditures
ChangesInAccruedExpensesRelatedToCapitalExpenditures
63000000 usd
CY2023Q1 chtr Changes In Accrued Expenses Related To Capital Expenditures
ChangesInAccruedExpensesRelatedToCapitalExpenditures
195000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
53000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
80000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2907000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2739000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5921000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7104000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5716000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6740000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2000000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
18000000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1328000000 usd
CY2024Q1 chtr Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
965000000 usd
CY2023Q4 chtr Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
681000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2557000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2802000000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10926000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
516000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
912000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
95000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
122000000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
3000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
3000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
56000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-353000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-695000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-111000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
709000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
645000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
661000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
534000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1236000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1189000000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
78000000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
61000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
850000000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
931000000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
520000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
509000000 usd
CY2024Q1 us-gaap Program Rights Obligations Current
ProgramRightsObligationsCurrent
1773000000 usd
CY2023Q4 us-gaap Program Rights Obligations Current
ProgramRightsObligationsCurrent
1736000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1018000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1283000000 usd
CY2024Q1 chtr Accrued Capital Expenditures
AccruedCapitalExpenditures
1838000000 usd
CY2023Q4 chtr Accrued Capital Expenditures
AccruedCapitalExpenditures
1944000000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1405000000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11214000000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
97777000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
97965000000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
84747000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
97588000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
97777000000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
87729000000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1557554 shares
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
516000000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2472915 shares
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
912000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
263000000 usd
CY2024Q1 chtr Noncontrolling Interest Purchaseof Interests Shares Purchased
NoncontrollingInterestPurchaseofInterestsSharesPurchased
262339 shares
CY2023Q1 chtr Noncontrolling Interest Purchaseof Interests Shares Purchased
NoncontrollingInterestPurchaseofInterestsSharesPurchased
324100 shares
CY2024Q1 chtr Minority Interest Decrease From Redemptions Purchase Price
MinorityInterestDecreaseFromRedemptionsPurchasePrice
95000000 usd
CY2023Q1 chtr Minority Interest Decrease From Redemptions Purchase Price
MinorityInterestDecreaseFromRedemptionsPurchasePrice
122000000 usd
CY2024Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-20000000 usd
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
5000000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
16000000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-32000000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4000000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-27000000 usd
CY2024Q1 us-gaap Revenues
Revenues
13679000000 usd
CY2023Q1 us-gaap Revenues
Revenues
13653000000 usd
CY2024Q1 chtr Programming Expense
ProgrammingExpense
2570000000 usd
CY2023Q1 chtr Programming Expense
ProgrammingExpense
2799000000 usd
CY2024Q1 chtr Franchise Regulatory And Connectivity Expense
FranchiseRegulatoryAndConnectivityExpense
1458000000 usd
CY2023Q1 chtr Franchise Regulatory And Connectivity Expense
FranchiseRegulatoryAndConnectivityExpense
1328000000 usd
CY2024Q1 chtr Cost To Service Customers
CostToServiceCustomers
2094000000 usd
CY2023Q1 chtr Cost To Service Customers
CostToServiceCustomers
2095000000 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
920000000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
946000000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1354000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1343000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
8396000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8511000000 usd
CY2024Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
13000000 usd
CY2023Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
10000000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
51000000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
38000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
67000000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4000000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-27000000 usd
CY2024Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-1000000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-2000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-86000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-89000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
208000000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18000000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1106000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1021000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144510317 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151438371 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2132882 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2099988 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146643199 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153538359 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.66
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.74
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.55
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.65
CY2024Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant or co-defendant in several lawsuits involving alleged infringement of various intellectual property relating to various aspects of its businesses. Other industry participants are also defendants in certain of these cases or related cases. In the event that a court ultimately determines that the Company infringes on any intellectual property, the Company may be subject to substantial damages and/or an injunction that could require the Company or its vendors to modify certain products and services the Company offers to its subscribers, as well as negotiate royalty or license agreements with respect to the intellectual property at issue. While the Company believes the lawsuits are without merit and intends to defend the actions vigorously, no assurance can be given that any adverse outcome would not be material to the Company’s operations, consolidated financial condition, results of operations, or liquidity. The Company cannot predict the outcome of any such claims nor can it reasonably estimate a range of possible loss.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to other lawsuits, claims and regulatory inquiries or investigations that arise in the ordinary course of conducting its business or in connection with the Company’s participation in government funding programs. The ultimate outcome of these other legal matters pending against the Company cannot be predicted, and although such lawsuits and claims are not expected individually to have a material adverse effect on the Company’s operations, consolidated financial condition, results of operations or liquidity, such lawsuits could have, in the aggregate, a material adverse effect on the Company’s operations, consolidated financial condition, results of operations or liquidity. Whether or not the Company ultimately prevails in any particular lawsuit or claim, litigation can be time consuming and costly and injure the Company’s reputation.</span></div>

Files In Submission

Name View Source Status
0001091667-24-000085-index-headers.html Edgar Link pending
0001091667-24-000085-index.html Edgar Link pending
0001091667-24-000085.txt Edgar Link pending
0001091667-24-000085-xbrl.zip Edgar Link pending
chtr-20240331.htm Edgar Link pending
chtr-20240331.xsd Edgar Link pending
chtr-20240331_g1.jpg Edgar Link pending
chtr3312024exh-311.htm Edgar Link pending
chtr3312024exh-312.htm Edgar Link pending
chtr3312024exh-321.htm Edgar Link pending
chtr3312024exh-322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
chtr-20240331_cal.xml Edgar Link unprocessable
chtr-20240331_def.xml Edgar Link unprocessable
chtr-20240331_pre.xml Edgar Link unprocessable
chtr-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chtr-20240331_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending